Conference abstract · 12 Jun 2019
Conference abstractPublished 26 Sep 2016
Targeted therapy in solid tumours
Queen’s NRI Hospital, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Chemotherapy for cancer treatment has been one of the major medical advances in the last few decades. However, the drugs used for chemotherapy have a narrow therapeutic index, with varied toxicities ranging from nausea to life threatening anaphylactic reactions, and often the responses produced are unpredictable. In contrast, targeted therapy that has been introduced in recent years is directed against cancer-specific molecules and signaling pathways and thus has more limited nonspecific toxicities. Discoveries important for survival, proliferation, and metastasis of different cancer cells combined with technological advances have produced agents that target proteins or genes critical in the neoplastic process. Tyrosine kinases are an especially important target because they play an important role in the modulation of growth factor signaling. Targeted therapies are of various types like tyrosine kinase inhibitors, monoclonal antibodies and conjugated antibodies. In this article we would like to mention about the improvement in treatment options, increase in response to treatment to various solid tumours as well as patient compliance to the treatment with targeted therapy especially Tyrosine Kinase Inhibitors (TKIs) and monoclonal antibodies (mab).
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 4 Apr 2023
Approaches for Targeting Tumour Metabolism during Cancer Therapy
Conference abstract · 14 Mar 2022
Targeting tumour-infiltrating myeloid cells for breast cancer therapy
Short communication · 19 Apr 2021
Pharmaceutical Chemistry and Pathology Congress 2019: Innovative and strategic materials against cancer: Preclinical researches on tumour accumulative novel sugar dendritic Gd-DTPA complex MRI contrast agents and IER5/Cdc25B targeted novel phospha sugar anti-tumour agents to innovate in cancer therapy - Mitsuji Yamashita - Shizuoka University
Conference abstract · 28 Jul 2016
Tumour associated Tie2+ macrophages: novel targets and effectors of anti-breast cancer therapies
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOncology & Cancer
- BylineArticles whose byline prints “B Ravi Shankar”
